Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01259596 · ClinicalTrials.gov registry record · NA
Telephone Psychotherapy for Late-Life Generalized Anxiety Disorder (GAD)
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 141
- Enrollment target
NCT01259596: Completed NA study, sponsored by Wake Forest University Health Sciences.
NCT01259596 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 141 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01259596, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 141 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if cognitive-behavioral therapy (CBT)and supportive therapy delivered by telephone are effective for reducing worry and anxiety in rural older adults with Generalized Anxiety Disorder (GAD).
Primary Outcome
self-reported severity and frequency of worry the scores range from 8 to 40, with higher scores representing higher severity of worry. Higher scores represent worse outcome.
Interventions
- BEHAVIORAL cognitive behavioral therapy
- BEHAVIORAL nondirective supportive therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 141 participants |
| Start Date | 2011-01 |
| Est. Completion | 2015-02 |
| Phase | NA |
What the finished NCT01259596 record still lists
NCT01259596 is an interventional study that assigns participants to a tested intervention. The registered 141 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 2 interventions - of which cognitive behavioral therapy is the first listed.
NCT01259596 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01259596 about?
NCT01259596 is a clinical study titled "Telephone Psychotherapy for Late-Life Generalized Anxiety Disorder (GAD)". The purpose of this study is to determine if cognitive-behavioral therapy (CBT)and supportive therapy delivered by telephone are effective for reducing worry and anxiety in rural older adults with Generalized Anxiety Disorder (GAD).
What is the current status of trial NCT01259596?
This trial is currently completed. It is a NA study. The enrollment target is 141 participants. The study started on 2011-01. Estimated completion is 2015-02.
What interventions are being tested in trial NCT01259596?
The interventions under investigation include: cognitive behavioral therapy (BEHAVIORAL), nondirective supportive therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT01259596?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01259596's enrollment target sits among peer trials
141 712th of 2000 higher than 1,288 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03042962 · 141 participants
Brain Networks in Dystonia
- NCT04378439 · 141 participants · NA
Appalachian Partnership to Reduce Disparities (Aim 2)
- NCT04775485 · 141 participants · Phase 2
A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors
- NCT05040360 · 141 participants · Phase 2
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia